Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Oncotarget|March 28, 2020
Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutationsAlberto Cruz-Bermúdez, Carmen G Vallejo, Ramiro J Vicente-Blanco, et al.
Oncotarget|April 25, 2015
Enhanced tumorigenicity by mitochondrial DNA mild mutationsAlberto Cruz-Bermúdez, Carmen G Vallejo, Ramiro J Vicente-Blanco, et al.
Plos One|January 20, 2016
Functional Characterization of Three Concomitant MtDNA LHON Mutations Shows No Synergistic Effect on Mitochondrial ActivityAlberto Cruz-Bermúdez, Ramiro J Vicente-Blanco, Rosana Hernández-Sierra, et al.
Scientific Reports|December 2, 2017
PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapyAlberto Cruz-Bermúdez, Ramiro J Vicente-Blanco, Raquel Laza-Briviesca, et al.
Free Radical Biology & Medicine|November 5, 2018
Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signalingAlberto Cruz-Bermúdez, Raquel Laza-Briviesca, Ramiro J Vicente-Blanco, et al.
Free Radical Biology & Medicine|March 19, 2019
Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibitionAlberto Cruz-Bermúdez, Raquel Laza-Briviesca, Ramiro J Vicente-Blanco, et al.
Pageof 1